Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity
Purpose: The authors report three separate cases of type 1 retinopathy of prematurity (ROP) treated with intravitreal bevacizumab before, or at 34 weeks postmenstrual age (PMA), with subsequent development of secondary glaucoma. Observations: All three cases involve patients born ≤24 weeks and meeti...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2024-12-01
|
| Serie: | American Journal of Ophthalmology Case Reports |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2451993624001415 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|